组织因子通路抑制剂-辅因子依赖调节凝血的启动
Josefin Ahnström1, Anastasis Petri, James T B Crawley
1Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Hospital Campus, Imperial College London, London, UK.
Current opinion in hematology
|September 11, 2024
概括
组织因子通路抑制剂α (TFPIα) 对于调节血液凝固和影响出血和血栓风险至关重要. 它的功能依赖于诸如蛋白质S和因子V-short (FV-short) 等辅助因子.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 组织因子通路抑制剂 (TFPI) 有两种异型:TFPIα和TFPIβ.
- TFPIα包括Kunitz域 (K1,K2,K3) 和一个基本的C端尾,而TFPIβ是细胞表面固定.
- TFPIα的域对因子VIIa和因子Xa具有特定的抑制作用,K3与蛋白S相互作用,C端结合FV-short.
研究的目的:
- 审查TFPI异型及其辅因子,蛋白S和FV-short的结构和功能.
- 探索TFPIα和TFPIβ在血液静止控制中的不同作用.
- 评估TFPI异型体对出血和血栓形成风险的贡献.
主要方法:
- 对TFPI结构,功能和异型的现有研究进行文献综述.
- 对蛋白S和FV-short作为TFPI辅因子的作用的数据分析.
- 评估TFPI异型体对血液静止和临床风险的影响.
主要成果:
- 最近的发现强调了TFPIα功能及其辅因子在血静调节中的重要性.
- TFPIα与蛋白S和FV-short的相互作用对于控制出血和血栓风险至关重要.
- TFPIβ的结构有助于它在细胞表面上固定.
结论:
- TFPIα是影响血栓形成和出血风险的主要TFPI池.
- TFPIα与FV-short和蛋白质S.形成了与血三分子复合体.
- FV-short水平调节循环TFPIα,S蛋白增强其抗凝活性.
相关概念视频
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K
01:09Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
01:16Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
01:05Introduction to Hemostasis
6.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.6K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K